Back to top
more

Elevance Health, Inc. (ELV)

(Delayed Data from NYSE)

$543.89 USD

543.89
943,115

+3.90 (0.72%)

Updated May 16, 2024 04:00 PM ET

After-Market: $544.17 +0.28 (0.05%) 7:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (94 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Lantheus (LNTH) Q4 Earnings Surpass Estimates, Gross Margin Up

Lantheus' (LNTH) robust segmental revenues drive its fourth-quarter performance.

3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio for Now

Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.

Apollo Medical Holdings, Inc. (AMEH) Soars 7.6%: Is Further Upside Left in the Stock?

Apollo Medical Holdings, Inc. (AMEH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Here's Why Elevance Health (ELV) Gained But Lagged the Market Today

Elevance Health (ELV) closed at $512.17 in the latest trading session, marking a +0.55% move from the prior day.

Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status

Better Therapeutics' (BTTX) novel CBT platform attains the FDA's breakthrough device designation to improve patient care in the treatment of liver and metabolic diseases.

Nevro's (NVRO) Q4 Earnings and Sales Top Estimates, Margins Up

Nevro's (NVRO) fourth-quarter earnings and revenues surpass their respective consensus estimate. The company incurs a loss in the operating level.

Glaukos (GKOS) Q4 Earnings Miss Estimates, Revenues Rise Y/Y

Glaukos' (GKOS) fourth-quarter revenues beat estimates as well as gained year over year. Gross margin improve, while higher operating expenses lead to a wider operating loss.

Masimo (MASI), UCHealth Unite to Improve Care With Telehealth

Masimo (MASI) collaborates with UCHealth to boost patient care by combining its latest virtual care technologies with UCHealth's clinical expertise and telehealth innovations.

Avanos (AVNS) Q4 Earnings Lag Estimates, Margins Contract

Despite strength in Avanos' (AVNS) Digestive Health segment, its overall fourth-quarter results reflect soft performances.

Boston Scientific (BSX) Completes First Case With Its PFA System

Boston Scientific (BSX) announces the completion of its first commercial cases with its FDA-cleared Farapulse PFA System in the United States.

Here's How Much a $1000 Investment in Elevance Health Made 10 Years Ago Would Be Worth Today

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

ELV or AMEH: Which Is the Better Value Stock Right Now?

ELV vs. AMEH: Which Stock Is the Better Value Option?

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year?

Here is how Elevance Health (ELV) and HCA Healthcare (HCA) have performed compared to their sector so far this year.

Merit Medical's (MMSI) SCOUT Guidance System Gets FDA Nod

Merit Medical's (MMSI) SCOUT MD Surgical Guidance System receives FDA clearance, which aims to boost the treatment of breast cancer by increasing accuracy to target tumor sites.

AngioDynamics (ANGO) Divests Its PICC & Midline Businesses

AngioDynamics (ANGO) finalizes its PICC and Midline businesses divestment to Spectrum Vascular to optimize its product portfolio and to focus on strengthening its med tech segment.

Integer Holdings (ITGR) Q4 Earnings and Sales Beat, Margins Up

Integer Holdings (ITGR) reports fourth-quarter results, with earnings and revenues beating their respective consensus marks.

PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down

PacBio (PACB) witnesses strong revenue growth in the fourth quarter, partly aided by customers' continued product transition to the Revio system.

AMN Healthcare (AMN) Q4 Earnings and Revenues Beat Estimates

AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall fourth-quarter performance.

Masimo's (MASI) MightySat Pulse Oximeter Receives FDA Approval

Masimo's (MASI) MightySat Medical Pulse Oximeter receives FDA clearance, which makes it the first FDA-approved pulse oximeter to be available OTC.

Veeva (VEEV) & Boehringer Partner to Boost Animal Healthcare

Veeva (VEEV) collaborates with Boehringer to offer its Veeva Vault Clinical and Veeva Vault RIM applications to improve animals??? healthcare via technological upliftment.

Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.

QuidelOrtho (QDEL) Q4 Earnings and Sales Miss, Margins Fall

Despite solid performances by the Labs segment and China and Other regions, QuidelOrtho (QDEL) misses earnings and revenue estimates by 41.8% and 6.9%, respectively.

DaVita (DVA) Q4 Earnings & Revenues Top Estimates, Margins Up

DaVita's (DVA) robust segmental revenues drive its fourth-quarter performance.

GE Healthcare (GEHC), MedQuest Partner to Boost Imaging Field

GE Healthcare (GEHC) collaborates with MedQuest to optimize outpatient imaging networks. With AI capabilities from GE Healthcare, MedQuest is likely to provide better solutions in the imaging space.

Cooper Companies (COO), Fulgent Unite to Boost Genetic Testing

Cooper Companies (COO) collaborates with Fulgent Genetics to boost newborn genetic screenings. CBR by Cooper Surgical is likely to provide a variety of genetic testing options to its families.